UPCC 11417: A Phase 3 Multicenter Randomized Open-Label Study of Guadecitabine (SGI-110) versus Treatment Choice in Adults with Previously Treated Acute Myeloid Leukemia
Request for collaborative review: WIRB serving as IRB of record.
- Study Identifier: 827342
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required